Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
CytoMed Therapeutics Gets Nasdaq Minimum Bid Price Deficiency Notice

CytoMed Therapeutics Gets Nasdaq Minimum Bid Price Deficiency Notice

MT newswireMT newswire2026/10/09 20:57

04:57 PM EDT, 10/09/2026 (MT Newswires) -- CytoMed Therapeutics (GDTC) said Friday it received a Nasdaq notice Tuesday stating that the closing bid price of its ordinary shares had remained below the $1 minimum bid price requirement for 30 consecutive business days. The company has 180 calendar days, or until April 5, 2027, to regain compliance with the requirement. CytoMed said it plans to take measures to regain compliance.

04:57 PM EDT, 10/09/2026 (MT Newswires) -- CytoMed Therapeutics (GDTC) said Friday it received a Nasdaq notice Tuesday stating that the closing bid price of its ordinary shares had remained below the $1 minimum bid price requirement for 30 consecutive business days. The company has 180 calendar days, or until April 5, 2027, to regain compliance with the requirement. CytoMed said it plans to take measures to regain compliance.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!